In a plot twist straight out of Orphan Black, the Supreme Court has ruled that naturally occurring DNA cannot be patented, but synthetic biological material is fair game. The case involved Myriad Genetics, a company specializing in molecular testing, after it tried to patent two genes -- BRCA1 and BRCA2 -- that are often linked to breast and ovarian cancer. The Association for Molecular Pathology filed the
